Výsledky vyhledávání - "Hélio Ha Carrara"

Abstract PS13-30: Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic

Autor: Francisco José Candido dos Reis, Franklin F Pimentel, Karoline Pi Peruchi, Hélio Ha Carrara, Jessica Mc Borba, Jurandyr Moreira de Andrade, Tamara Cgf Rodrigues

Publikováno v: Cancer Research. 81:PS13-30

Background COVID-19 pandemic presented as a challenge to breast cancer (BC) treatment, especially considering safety concerns and resource scarcity. Treatment choices have been taken mainly based on safety according to guidelines which aim hierarchic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aba7132c47b68310a3c6924014628f78
https://doi.org/10.1158/1538-7445.sabcs20-ps13-30

Zobrazit plný text záznamu

Abstract P2-08-31: Role of body mass index in Brazilian breast cancer patients: Clinical-pathological characteristics and outcome in a single-institution retrospective cohort

Autor: Leonardo Fleury Orlandini, Francisco Jc dos Reis, Jurandyr Moreira de Andrade, Franklin F Pimentel, Daniel Guimarães Tiezzi, Hélio Ha Carrara

Publikováno v: Cancer Research. 80:P2-08

Background: Despite of several studies described body mass index (BMI) as a poor prognostic factor in breast cancer (BC) patients, the available data are still conflicting and the relation between obesity and BC remains unclear. In this study we eval

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ac4c48e63aa45616e15ff4e8f702765
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-31

Zobrazit plný text záznamu

Abstract P2-08-22: Adjuvant trastuzumab effectiveness in a cohort of HER2-positive breast cancer Brazilian patients treated in a public hospital: The impact in public health planning compared to clinical trial data

Autor: Leonardo Fleury Orlandini, Francisco J.C. dos Reis, Franklin F Pimentel, Daniel Guimarães Tiezzi, Jurandyr Moreira de Andrade, Hélio Ha Carrara

Publikováno v: Cancer Research. 80:P2-08

Background: About 20% of breast cancer (BC) subtypes are classified as HER2-positive (HER2+), recognized as a biomarker for worse prognosis. Trastuzumab (T) is a monoclonal antibody approved to treat HER2+ early BC since 2006 and included in the Worl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cb29a5f6d49f540fb35507f4c3030150
https://doi.org/10.1158/1538-7445.sabcs19-p2-08-22

Zobrazit plný text záznamu

1747P Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: Patterns in a Brazilian University Hospital

Autor: J.M. de Andrade, Karoline Pi Peruchi, Hélio Ha Carrara, F. J. Candido dos Reis, Tamara Cgf Rodrigues, Franklin F Pimentel, Jessica Maria Camargo Borba

Publikováno v: Annals of Oncology

Background: Cancer treatment during COVID-19 pandemic have been mainly focused on safety, and prioritization has been done to guide hierarchically choices according to clinical benefits considering resource scarcity Considering the magnitude of benef

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3b35c980e87524622ce96ee8d67f2d3
https://doi.org/10.1016/j.annonc.2020.08.1811

Zobrazit plný text záznamu

Abstract 3350: Cancer stem cells and lymph node metastasis in early stage breast cancer

Autor: João Santana da Silva, Luciana Benevides, H. R. C. Marana, Willian Simões Clagnan, Fernando Am Valejo, Hélio Ha Carrara, Daniel Guimarães Tiezzi, Jurandyr Moreira de Andrade

Publikováno v: Cancer Research. 70:3350-3350

Breast cancer is the leading cause of malignancy in women worldwide. Metastatic dissemination is the major cause of death. The mechanisms involved in cancer dissemination are unclear. The identification of tumor initiating cells in solid tumors has b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6db96e5a6891d7a21e4358b98fc3d010
https://doi.org/10.1158/1538-7445.am10-3350

Zobrazit plný text záznamu

Sub-group analysis of response, overall survival, and quality of life (QoL) with gemcitabine-cisplatin (G-C) in anthracycline and taxane pretreated metastatic breast cancer

Autor: Daniel Guimarães Tiezzi, Luiz Gustavo Oliveira Brito, Fernanda Maris Peria, Jurandyr Moreira de Andrade, Hélio Ha Carrara, F. E. Zola, T. C. Motta

Publikováno v: Journal of Clinical Oncology. 26:12000-12000

12000 Background: Chemotherapy is an important treatment of metastatic breast cancer (MBC) and G-C is an option to taxane and anthracycline pretreated patients. The main objective is to analyze the impact of tumor and patients characteristics in G-C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9d79c603fb19edb27e2d3b78cb3066e7
https://doi.org/10.1200/jco.2008.26.15_suppl.12000

Zobrazit plný text záznamu

Combination chemotherapy with gencitabine and cisplatin in anthracycline and taxane pretreated metastatic breast cancer

Autor: Fernanda Maris Peria, Jurandyr Moreira de Andrade, F. E. Zola, P M P Philbert, Hélio Ha Carrara, H. R. C. Marana, Daniel Guimarães Tiezzi

Publikováno v: Journal of Clinical Oncology. 25:1108-1108

1108 Background: Metastatic breast cancer (MBC) anthracycline (A) and taxane (T) resistant has a complicated management.Combination chemotherapy, even in 2nd line, may have advantages over single agent therapy. Gencitabine (G) - cisplatin (C) combina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa260a65c196bcc3ae6a524231b3b737
https://doi.org/10.1200/jco.2007.25.18_suppl.1108

Zobrazit plný text záznamu

Primary chemotherapy in breast cancer shows excellent clinical and pathological response with docetaxel and epirubicin

Autor: Jurandyr Moreira de Andrade, Hélio Ha Carrara, H. R. C. Marana, F. E. Zola, F.J.C. Reis, S. Bighetti, Daniel Guimarães Tiezzi

Publikováno v: Journal of Clinical Oncology. 24:10779-10779

10779 Background: Primary chemotherapy is becoming the standard of care for locally advanced breast cancer. Recently tested regimens using new drugs have been showing better results than usual anthracycline based treatments. Methods: From April 1998

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f48180816668b062833d7f83da1b5662
https://doi.org/10.1200/jco.2006.24.18_suppl.10779

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání